▶ 調査レポート

バイオシミラー/バイオ後続品の世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Biosimilars/Follow-on-Biologics Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。バイオシミラー/バイオ後続品の世界市場 2020年:メーカー別、地域別、種類・用途別 / Global Biosimilars/Follow-on-Biologics Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D005-03041資料のイメージです。• レポートコード:D005-03041
• 出版社/出版日:GlobalInfoResearch / 2020年5月22日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、106ページ
• 納品方法:Eメール
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、バイオシミラー/バイオ後続品の世界市場を広く調査・分析し、今後の市場展望をまとめております。バイオシミラー/バイオ後続品の種類別市場規模(ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子、ペプチド、その他)、用途別市場規模(血液疾患、腫瘍疾患、慢性・自己免疫疾患、成長ホルモン欠乏症、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Novartis、Merck Group、LG Life Sciences、Synthon Pharmaceuticals、Hospira、Teva Pharmaceutical Industries、Genentech (Roche Group)、Biocon、Celltrion、Biogen idec, Inc.
・地域別グローバル市場分析 2015年-2020年
・バイオシミラー/バイオ後続品の北米市場(アメリカ、カナダ、メキシコ)
・バイオシミラー/バイオ後続品のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・バイオシミラー/バイオ後続品のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・バイオシミラー/バイオ後続品の南米市場(ブラジル、アルゼンチン)
・バイオシミラー/バイオ後続品の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子、ペプチド、その他
・用途別分析:血液疾患、腫瘍疾患、慢性・自己免疫疾患、成長ホルモン欠乏症、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Biosimilars/Follow-on-Biologics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Biosimilars/Follow-on-Biologics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Biosimilars/Follow-on-Biologics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Biosimilars/Follow-on-Biologics market has been segmented into
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Peptide
Others

By Application, Biosimilars/Follow-on-Biologics has been segmented into:
Blood disorders
Oncology diseases
Chronic and autoimmune diseases
Growth hormone deficiencies
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biosimilars/Follow-on-Biologics market presented in the report. This section sheds light on the sales growth of different regional and country-level Biosimilars/Follow-on-Biologics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biosimilars/Follow-on-Biologics market.

The report offers in-depth assessment of the growth and other aspects of the Biosimilars/Follow-on-Biologics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Biosimilars/Follow-on-Biologics Market Share Analysis
Biosimilars/Follow-on-Biologics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biosimilars/Follow-on-Biologics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biosimilars/Follow-on-Biologics sales, revenue and market share for each player covered in this report.

The major players covered in Biosimilars/Follow-on-Biologics are:
Novartis
Merck Group
LG Life Sciences
Synthon Pharmaceuticals
Hospira
Teva Pharmaceutical Industries
Genentech (Roche Group)
Biocon
Celltrion
Biogen idec, Inc.

Among other players domestic and global, Biosimilars/Follow-on-Biologics market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biosimilars/Follow-on-Biologics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biosimilars/Follow-on-Biologics, with price, sales, revenue and global market share of Biosimilars/Follow-on-Biologics in 2018 and 2019.
Chapter 3, the Biosimilars/Follow-on-Biologics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosimilars/Follow-on-Biologics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Biosimilars/Follow-on-Biologics market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Biosimilars/Follow-on-Biologics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Biosimilars/Follow-on-Biologics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biosimilars/Follow-on-Biologics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Human growth hormone
1.2.3 Erythropoietin
1.2.4 Monoclonal antibodies
1.2.5 Insulin
1.2.6 Interferon
1.2.7 Granulocyte-Colony Stimulating Factor
1.2.8 Peptide
1.2.9 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Biosimilars/Follow-on-Biologics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Blood disorders
1.3.3 Oncology diseases
1.3.4 Chronic and autoimmune diseases
1.3.5 Growth hormone deficiencies
1.3.6 Others
1.4 Overview of Global Biosimilars/Follow-on-Biologics Market
1.4.1 Global Biosimilars/Follow-on-Biologics Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck Group
2.2.1 Merck Group Details
2.2.2 Merck Group Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck Group SWOT Analysis
2.2.4 Merck Group Product and Services
2.2.5 Merck Group Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 LG Life Sciences
2.3.1 LG Life Sciences Details
2.3.2 LG Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 LG Life Sciences SWOT Analysis
2.3.4 LG Life Sciences Product and Services
2.3.5 LG Life Sciences Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Synthon Pharmaceuticals
2.4.1 Synthon Pharmaceuticals Details
2.4.2 Synthon Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Synthon Pharmaceuticals SWOT Analysis
2.4.4 Synthon Pharmaceuticals Product and Services
2.4.5 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Hospira
2.5.1 Hospira Details
2.5.2 Hospira Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Hospira SWOT Analysis
2.5.4 Hospira Product and Services
2.5.5 Hospira Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Teva Pharmaceutical Industries
2.6.1 Teva Pharmaceutical Industries Details
2.6.2 Teva Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Teva Pharmaceutical Industries SWOT Analysis
2.6.4 Teva Pharmaceutical Industries Product and Services
2.6.5 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Genentech (Roche Group)
2.7.1 Genentech (Roche Group) Details
2.7.2 Genentech (Roche Group) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Genentech (Roche Group) SWOT Analysis
2.7.4 Genentech (Roche Group) Product and Services
2.7.5 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Biocon
2.8.1 Biocon Details
2.8.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Biocon SWOT Analysis
2.8.4 Biocon Product and Services
2.8.5 Biocon Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Celltrion
2.9.1 Celltrion Details
2.9.2 Celltrion Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Celltrion SWOT Analysis
2.9.4 Celltrion Product and Services
2.9.5 Celltrion Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Biogen idec, Inc.
2.10.1 Biogen idec, Inc. Details
2.10.2 Biogen idec, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Biogen idec, Inc. SWOT Analysis
2.10.4 Biogen idec, Inc. Product and Services
2.10.5 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Biosimilars/Follow-on-Biologics Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Biosimilars/Follow-on-Biologics Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Biosimilars/Follow-on-Biologics Manufacturer Market Share in 2019
3.3.2 Top 6 Biosimilars/Follow-on-Biologics Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Biosimilars/Follow-on-Biologics Sales, Revenue and Market Share by Regions
4.1.1 Global Biosimilars/Follow-on-Biologics Sales and Market Share by Regions (2015-2020)
4.1.2 Global Biosimilars/Follow-on-Biologics Revenue and Market Share by Regions (2015-2020)
4.2 North America Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
4.3 Europe Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
4.5 South America Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Biosimilars/Follow-on-Biologics Sales, Revenue and Market Share by Country
5.1.1 North America Biosimilars/Follow-on-Biologics Sales and Market Share by Country (2015-2020)
5.1.2 North America Biosimilars/Follow-on-Biologics Revenue and Market Share by Country (2015-2020)
5.2 United States Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
5.3 Canada Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
5.4 Mexico Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Biosimilars/Follow-on-Biologics Sales, Revenue and Market Share by Country
6.1.1 Europe Biosimilars/Follow-on-Biologics Sales and Market Share by Country (2015-2020)
6.1.2 Europe Biosimilars/Follow-on-Biologics Revenue and Market Share by Country (2015-2020)
6.2 Germany Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
6.3 UK Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
6.4 France Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
6.5 Russia Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
6.6 Italy Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Biosimilars/Follow-on-Biologics Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Biosimilars/Follow-on-Biologics Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Biosimilars/Follow-on-Biologics Revenue and Market Share by Regions (2015-2020)
7.2 China Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
7.3 Japan Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
7.4 Korea Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
7.5 India Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
7.7 Australia Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Biosimilars/Follow-on-Biologics Sales, Revenue and Market Share by Country
8.1.1 South America Biosimilars/Follow-on-Biologics Sales and Market Share by Country (2015-2020)
8.1.2 South America Biosimilars/Follow-on-Biologics Revenue and Market Share by Country (2015-2020)
8.2 Brazil Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
8.3 Argentina Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Biosimilars/Follow-on-Biologics Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Biosimilars/Follow-on-Biologics Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Biosimilars/Follow-on-Biologics Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
9.3 Turkey Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
9.4 Egypt Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
9.5 South Africa Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Biosimilars/Follow-on-Biologics Sales and Market Share by Type (2015-2020)
10.2 Global Biosimilars/Follow-on-Biologics Revenue and Market Share by Type (2015-2020)
10.3 Global Biosimilars/Follow-on-Biologics Price by Type (2015-2020)
11 Global Biosimilars/Follow-on-Biologics Market Segment by Application
11.1 Global Biosimilars/Follow-on-Biologics Sales Market Share by Application (2015-2020)
11.2 Global Biosimilars/Follow-on-Biologics Revenue Market Share by Application (2015-2020)
11.3 Global Biosimilars/Follow-on-Biologics Price by Application (2015-2020)
12 Market Forecast
12.1 Global Biosimilars/Follow-on-Biologics Sales, Revenue and Growth Rate (2021-2025)
12.2 Biosimilars/Follow-on-Biologics Market Forecast by Regions (2021-2025)
12.2.1 North America Biosimilars/Follow-on-Biologics Market Forecast (2021-2025)
12.2.2 Europe Biosimilars/Follow-on-Biologics Market Forecast (2021-2025)
12.2.3 Asia-Pacific Biosimilars/Follow-on-Biologics Market Forecast (2021-2025)
12.2.4 South America Biosimilars/Follow-on-Biologics Market Forecast (2021-2025)
12.2.5 Middle East & Africa Biosimilars/Follow-on-Biologics Market Forecast (2021-2025)
12.3 Biosimilars/Follow-on-Biologics Market Forecast by Type (2021-2025)
12.3.1 Global Biosimilars/Follow-on-Biologics Sales Forecast by Type (2021-2025)
12.3.2 Global Biosimilars/Follow-on-Biologics Market Share Forecast by Type (2021-2025)
12.4 Biosimilars/Follow-on-Biologics Market Forecast by Application (2021-2025)
12.4.1 Global Biosimilars/Follow-on-Biologics Sales Forecast by Application (2021-2025)
12.4.2 Global Biosimilars/Follow-on-Biologics Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Biosimilars/Follow-on-Biologics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biosimilars/Follow-on-Biologics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biosimilars/Follow-on-Biologics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Biosimilars/Follow-on-Biologics Major Business
Table 9. Novartis Biosimilars/Follow-on-Biologics Total Revenue (USD Million) (2018-2019)
Table 10. Novartis SWOT Analysis
Table 11. Novartis Biosimilars/Follow-on-Biologics Product and Services
Table 12. Novartis Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Merck Group Basic Information, Manufacturing Base and Competitors
Table 14. Merck Group Biosimilars/Follow-on-Biologics Major Business
Table 15. Merck Group Biosimilars/Follow-on-Biologics Total Revenue (USD Million) (2018-2019)
Table 16. Merck Group SWOT Analysis
Table 17. Merck Group Biosimilars/Follow-on-Biologics Product and Services
Table 18. Merck Group Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 20. LG Life Sciences Biosimilars/Follow-on-Biologics Major Business
Table 21. LG Life Sciences Biosimilars/Follow-on-Biologics Total Revenue (USD Million) (2018-2019)
Table 22. LG Life Sciences SWOT Analysis
Table 23. LG Life Sciences Biosimilars/Follow-on-Biologics Product and Services
Table 24. LG Life Sciences Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Synthon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 26. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Major Business
Table 27. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Total Revenue (USD Million) (2018-2019)
Table 28. Synthon Pharmaceuticals SWOT Analysis
Table 29. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Product and Services
Table 30. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Hospira Basic Information, Manufacturing Base and Competitors
Table 32. Hospira Biosimilars/Follow-on-Biologics Major Business
Table 33. Hospira Biosimilars/Follow-on-Biologics Total Revenue (USD Million) (2018-2019)
Table 34. Hospira SWOT Analysis
Table 35. Hospira Biosimilars/Follow-on-Biologics Product and Services
Table 36. Hospira Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 38. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Major Business
Table 39. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Total Revenue (USD Million) (2018-2019)
Table 40. Teva Pharmaceutical Industries SWOT Analysis
Table 41. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Product and Services
Table 42. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Genentech (Roche Group) Basic Information, Manufacturing Base and Competitors
Table 44. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Major Business
Table 45. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Total Revenue (USD Million) (2018-2019)
Table 46. Genentech (Roche Group) SWOT Analysis
Table 47. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Product and Services
Table 48. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Biocon Basic Information, Manufacturing Base and Competitors
Table 50. Biocon Biosimilars/Follow-on-Biologics Major Business
Table 51. Biocon Biosimilars/Follow-on-Biologics Total Revenue (USD Million) (2018-2019)
Table 52. Biocon SWOT Analysis
Table 53. Biocon Biosimilars/Follow-on-Biologics Product and Services
Table 54. Biocon Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Celltrion Basic Information, Manufacturing Base and Competitors
Table 56. Celltrion Biosimilars/Follow-on-Biologics Major Business
Table 57. Celltrion Biosimilars/Follow-on-Biologics Total Revenue (USD Million) (2018-2019)
Table 58. Celltrion SWOT Analysis
Table 59. Celltrion Biosimilars/Follow-on-Biologics Product and Services
Table 60. Celltrion Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Biogen idec, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Major Business
Table 63. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Total Revenue (USD Million) (2018-2019)
Table 64. Biogen idec, Inc. SWOT Analysis
Table 65. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Product and Services
Table 66. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Biosimilars/Follow-on-Biologics Sales by Manufacturer (2018-2019) (K Pcs)
Table 68. Global Biosimilars/Follow-on-Biologics Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Biosimilars/Follow-on-Biologics Sales by Regions (2015-2020) (K Pcs)
Table 70. Global Biosimilars/Follow-on-Biologics Sales Market Share by Regions (2015-2020)
Table 71. Global Biosimilars/Follow-on-Biologics Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Biosimilars/Follow-on-Biologics Sales by Countries (2015-2020) (K Pcs)
Table 73. North America Biosimilars/Follow-on-Biologics Sales Market Share by Countries (2015-2020)
Table 74. North America Biosimilars/Follow-on-Biologics Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Biosimilars/Follow-on-Biologics Revenue Market Share by Countries (2015-2020)
Table 76. Europe Biosimilars/Follow-on-Biologics Sales by Countries (2015-2020) (K Pcs)
Table 77. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Countries (2015-2020)
Table 78. Europe Biosimilars/Follow-on-Biologics Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Biosimilars/Follow-on-Biologics Sales by Regions (2015-2020) (K Pcs)
Table 80. Asia-Pacific Biosimilars/Follow-on-Biologics Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Biosimilars/Follow-on-Biologics Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Biosimilars/Follow-on-Biologics Sales by Countries (2015-2020) (K Pcs)
Table 83. South America Biosimilars/Follow-on-Biologics Sales Market Share by Countries (2015-2020)
Table 84. South America Biosimilars/Follow-on-Biologics Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Biosimilars/Follow-on-Biologics Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Countries (2015-2020) (K Pcs)
Table 87. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue Market Share by Countries (2015-2020)
Table 90. Global Biosimilars/Follow-on-Biologics Sales by Type (2015-2020) (K Pcs)
Table 91. Global Biosimilars/Follow-on-Biologics Sales Share by Type (2015-2020)
Table 92. Global Biosimilars/Follow-on-Biologics Revenue by Type (2015-2020) (USD Million)
Table 93. Global Biosimilars/Follow-on-Biologics Revenue Share by Type (2015-2020)
Table 94. Global Biosimilars/Follow-on-Biologics Sales by Application (2015-2020) (K Pcs)
Table 95. Global Biosimilars/Follow-on-Biologics Sales Share by Application (2015-2020)
Table 96. Global Biosimilars/Follow-on-Biologics Sales Forecast by Regions (2021-2025) (K Pcs)
Table 97. Global Biosimilars/Follow-on-Biologics Market Share Forecast by Regions (2021-2025)
Table 98. Global Biosimilars/Follow-on-Biologics Sales Forecast by Type (2021-2025) (K Pcs)
Table 99. Global Biosimilars/Follow-on-Biologics Market Share Forecast by Type (2021-2025)
Table 100. Global Biosimilars/Follow-on-Biologics Sales Forecast by Application (2021-2025)
Table 101. Global Biosimilars/Follow-on-Biologics Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Biosimilars/Follow-on-Biologics Picture
Figure 2. Global Sales Market Share of Biosimilars/Follow-on-Biologics by Type in 2019
Figure 3. Human growth hormone Picture
Figure 4. Erythropoietin Picture
Figure 5. Monoclonal antibodies Picture
Figure 6. Insulin Picture
Figure 7. Interferon Picture
Figure 8. Granulocyte-Colony Stimulating Factor Picture
Figure 9. Peptide Picture
Figure 10. Others Picture
Figure 11. Biosimilars/Follow-on-Biologics Sales Market Share by Application in 2018
Figure 12. Blood disorders Picture
Figure 13. Oncology diseases Picture
Figure 14. Chronic and autoimmune diseases Picture
Figure 15. Growth hormone deficiencies Picture
Figure 16. Others Picture
Figure 17. Global Biosimilars/Follow-on-Biologics Market Status and Outlook (2015-2025) (USD Million)
Figure 18. United States Biosimilars/Follow-on-Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Canada Biosimilars/Follow-on-Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Mexico Biosimilars/Follow-on-Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Germany Biosimilars/Follow-on-Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 22. France Biosimilars/Follow-on-Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 23. UK Biosimilars/Follow-on-Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Russia Biosimilars/Follow-on-Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Italy Biosimilars/Follow-on-Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 26. China Biosimilars/Follow-on-Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Japan Biosimilars/Follow-on-Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Korea Biosimilars/Follow-on-Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 29. India Biosimilars/Follow-on-Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Southeast Asia Biosimilars/Follow-on-Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Australia Biosimilars/Follow-on-Biologics Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 32. Brazil Biosimilars/Follow-on-Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Egypt Biosimilars/Follow-on-Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Saudi Arabia Biosimilars/Follow-on-Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 35. South Africa Biosimilars/Follow-on-Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Turkey Biosimilars/Follow-on-Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 37. Global Biosimilars/Follow-on-Biologics Sales Market Share by Manufacturer in 2019
Figure 38. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Manufacturer in 2019
Figure 39. Top 3 Biosimilars/Follow-on-Biologics Manufacturer (Revenue) Market Share in 2019
Figure 40. Top 6 Biosimilars/Follow-on-Biologics Manufacturer (Revenue) Market Share in 2019
Figure 41. Key Manufacturer Market Share Trend
Figure 42. Global Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 43. Global Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Regions (2015-2020)
Figure 45. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Regions in 2018
Figure 46. North America Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
Figure 47. Europe Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
Figure 48. Asia-Pacific Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
Figure 49. South America Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
Figure 50. Middle East & Africa Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
Figure 51. North America Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. North America Biosimilars/Follow-on-Biologics Sales Market Share by Countries (2015-2020)
Figure 53. North America Biosimilars/Follow-on-Biologics Sales Market Share by Countries in 2018
Figure 54. North America Biosimilars/Follow-on-Biologics Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 55. North America Biosimilars/Follow-on-Biologics Revenue Market Share by Countries in 2018
Figure 56. United States Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. Canada Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. Mexico Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. Europe Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Europe Biosimilars/Follow-on-Biologics Revenue Market Share by Countries (2015-2020)
Figure 61. Europe Biosimilars/Follow-on-Biologics Revenue Market Share by Countries in 2019
Figure 62. Germany Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. UK Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. France Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Russia Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Italy Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Asia-Pacific Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. Asia-Pacific Biosimilars/Follow-on-Biologics Sales Market Share by Regions 2019
Figure 69. Asia-Pacific Biosimilars/Follow-on-Biologics Revenue Market Share by Regions 2019
Figure 70. China Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Japan Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. Korea Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. India Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Southeast Asia Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. South America Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. South America Biosimilars/Follow-on-Biologics Sales Market Share by Countries in 2019
Figure 77. South America Biosimilars/Follow-on-Biologics Revenue Market Share by Countries in 2019
Figure 78. Brazil Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. Argentina Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Middle East and Africa Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 81. Middle East and Africa Biosimilars/Follow-on-Biologics Sales Market Share by Countries in 2019
Figure 82. Middle East and Africa Biosimilars/Follow-on-Biologics Revenue Market Share by Countries (2015-2020)
Figure 83. Middle East and Africa Biosimilars/Follow-on-Biologics Revenue Market Share by Countries in 2019
Figure 84. Saudi Arabia Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Egypt Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 86. Turkey Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 87. South Africa Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 88. Global Biosimilars/Follow-on-Biologics Sales and Growth Rate (2021-2025) (K Pcs)
Figure 89. Global Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2021-2025) (USD Million)
Figure 90. North America Sales Biosimilars/Follow-on-Biologics Market Forecast (2021-2025) (K Pcs)
Figure 91. Europe Sales Biosimilars/Follow-on-Biologics Market Forecast (2021-2025) (K Pcs)
Figure 92. Asia-Pacific Sales Biosimilars/Follow-on-Biologics Market Forecast (2021-2025) (K Pcs)
Figure 93. South America Sales Biosimilars/Follow-on-Biologics Market Forecast (2021-2025) (K Pcs)
Figure 94. Middle East & Africa Sales Biosimilars/Follow-on-Biologics Market Forecast (2021-2025) (K Pcs)
Figure 95. Sales Channel: Direct Channel vs Indirect Channel